全文获取类型
收费全文 | 243篇 |
免费 | 15篇 |
国内免费 | 46篇 |
出版年
2024年 | 1篇 |
2023年 | 5篇 |
2022年 | 6篇 |
2021年 | 21篇 |
2020年 | 6篇 |
2019年 | 15篇 |
2018年 | 11篇 |
2017年 | 5篇 |
2016年 | 9篇 |
2015年 | 13篇 |
2014年 | 28篇 |
2013年 | 23篇 |
2012年 | 30篇 |
2011年 | 33篇 |
2010年 | 18篇 |
2009年 | 21篇 |
2008年 | 10篇 |
2007年 | 10篇 |
2006年 | 6篇 |
2005年 | 10篇 |
2004年 | 5篇 |
2003年 | 6篇 |
2002年 | 3篇 |
2000年 | 1篇 |
1999年 | 1篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 1篇 |
1992年 | 2篇 |
1986年 | 1篇 |
排序方式: 共有304条查询结果,搜索用时 671 毫秒
71.
Dongyan Liu Xiaonan Hou Wangyu Wu Valentina Zanfagnin Yunjian Li Cristina Correia Zhiyang Zhao Chenggang Zhao Zhirong Liu Tao Zhang Zhiyou Fang Hongzhi Wang Chao Xu Saravut J. Weroha Scott H. Kaufmann Haiming Dai 《Cell death & disease》2021,12(8)
We previously found that preformed complexes of BAK with antiapoptotic BCL2 proteins predict BH3 mimetic sensitivities in lymphohematopoietic cells. These complexes have not previously been examined in solid tumors or in the context of conventional anticancer drugs. Here we show the relative amount of BAK found in preformed complexes with MCL1 or BCLXL varies across ovarian cancer cell lines and patient-derived xenografts (PDXs). Cells bearing BAK/MCL1 complexes were more sensitive to paclitaxel and the MCL1 antagonist . Likewise, PDX models with BAK/MCL1 complexes were more likely to respond to paclitaxel. Mechanistically, BIM induced by low paclitaxel concentrations interacted preferentially with MCL1 and displaced MCL1-bound BAK. Further studies indicated that cells with preformed BAK/MCL1 complexes were sensitive to the paclitaxel/ S63845 combination, while cells without BAK/MCL1 complexes were not. Our study suggested that the assessment of BAK/MCL1 complexes might be useful for predicting response to paclitaxel alone or in combination with BH3 mimetics.Subject terms: S63845Chemotherapy, Apoptosis 相似文献
72.
Chao Gao Jianhua Qiu Jingchen Li Cuiqing Ma Hongzhi Tang Ping Xu 《Bioresource technology》2009,100(5):1878-1880
d-Lactic acid and pyruvic acid are two important building block intermediates. Production of d-lactic acid and pyruvic acid from racemic lactic acid by biotransformation is economically interesting. Biocatalyst prepared from 9 g dry cell wt l?1 of Pseudomonas stutzeri SDM could catalyze 45.00 g l?1 dl-lactic acid into 25.23 g l?1 d-lactic acid and 19.70 g l?1 pyruvic acid in 10 h. Using a simple ion exchange process, d-lactic acid and pyruvic acid were effectively separated from the biotransformation system. Co-production of d-lactic acid and pyruvic acid by enantioselective oxidation of racemic lactic acid is technically feasible. 相似文献
73.
Oncostatin M (OSM) is a multifunctional cellular regulator that belongs to the IL-6 subfamily and can act on a wide variety of cells, which has potential roles in the regulation of gene activation, cell survival, proliferation and differentiation. In order to achieve the higher level yield of recombinant human Oncostatin M (rhOSM), we determined the optimal pH condition of rhOSM expressed in the methylotrophic yeast Pichia pastoris X-33 and carried out the fermentation culture of rhOSM in 80 L fermentor in a fed-batch mode. SDS–PAGE and Western blotting assays demonstrated that rhOSM was successfully expressed and secreted into the culture medium with an apparent molecular weight of 28 kDa. N-terminals were correctly processed through amino-terminal sequencing. The maximum yield of rhOSM was 280 mg/L. rhOSM was purified by phenyl Sepharose hydrophobic interaction chromatography and SP Sepharose Fast Flow cation exchange chromatography, which resulted in a final yield of purified rhOSM of 6.94 g with a recovery of 62% and a purity of 95%. The purified rhOSM had a specific growth inhibition activity of 6.26 × 104 RU/μg, which was commensurate with typical values (6.2 × 104 RU/μg) obtained with standard hOSM. 相似文献
74.
75.
Chunyu Yang Yang Li Kun Zhang Xia Wang Cuiqing Ma Hongzhi Tang Ping Xu 《Biodegradation》2010,21(1):97-105
A simple consortium consisted of two members of Klebsiella sp. A1 and Comamonas sp. A2 was isolated from the sewage of a pesticide mill in China. One member of Klebsiella sp. A1 is a novel strain that could use atrazine as the sole carbon and nitrogen source. The consortium showed high atrazine-mineralizing
efficiency and about 83.3% of 5 g l−1 atrazine could be mineralized after 24 h degradation. Contrary to many other reported microorganisms, the consortium was
insensitive to some nitrogenous fertilizers commonly used, not only in presence of 200 mg l−1 atrazine but also in 5 g l−1 atrazine mediums. After 24 h incubation, 200 mg l−1 atrazine was completely mineralized despite of the presence of urea, (NH4)2CO3 and (NH4)2HPO4 in the medium. Very minor influence was observed when NH4Cl was added as additional nitrogen source. Advantages of the simple consortium, high mineralizing efficiency and insensitivity
to most of exogenous nitrogen sources, all suggested application potential of the consortium for the bioremediation of atrazine-contaminated
soils and waters. 相似文献
76.
木酮糖激酶基因整合表达载体构建及在酿酒酵母中的过表达 总被引:1,自引:0,他引:1
【目的】以载体p406ADH1为构建骨架,构建一个酿酒酵母(Saccharomyces cerevisiae)工业菌株的整合表达载体。【方法】通过酶切连接的方式,将4个元件片段:作为筛选标记的G418抗性基因KanR,用于基因表达的ADH1终止子片段,酿酒酵母W5自身木酮糖激酶基因,18S rDNA介导的同源整合区,插入到骨架质粒p406ADH1中,得到多拷贝整合表达载体pCXS-RKTr。将该载体线性转化酿酒酵母后,对转化子中木酮糖激酶酶活进行测定,检测其表达情况。【结果】重组质粒在酿酒酵母体内实现了木酮糖激酶的高水平稳定表达,其酶活力是初始菌株的2.87倍。【结论】本实验构建了一个酿酒酵母工业菌株整合表达载体,并用此载体过表达了其自身的木酮糖激酶基因。该重组质粒载体的构建可以有效解决酿酒酵母中自身木酮糖激酶酶活较低的情况,这为利用木糖高产乙醇酿酒酵母基因工程菌株的构建和其它酵母重组质粒载体的构建奠定基础。 相似文献
77.
Limburg DC Thomas BE Li JH Fuller M Spicer D Chen Y Guo H Steiner JP Hamilton GS Wu YQ 《Bioorganic & medicinal chemistry letters》2003,13(21):3867-3870
As part of our ongoing program to explore novel structural classes of FKBP12 ligands, we herein wish to report a new class of FKBP12 ligands containing chiral bicyclic proline analogues. Details of the synthetic routes, together with preliminary biological activity, will be presented. 相似文献
78.
79.
Houyi Sun Weicheng Zhang Ning Yang Yi Xue Tianhao Wang Hongzhi Wang Kai Zheng Yijun Wang Feng Zhu Huilin Yang Wei Xu Yaozeng Xu Dechun Geng 《Cell death & disease》2021,12(11)
In glucocorticoid (GC)-induced osteonecrosis of the femoral head (ONFH), downregulated osteogenic ability and damaged blood supply are two key pathogenic mechanisms. Studies suggested that cannabinoid receptor 2 (CB2) is expressed in bone tissue and it plays a positive role in osteogenesis. However, whether CB2 could enhance bone formation and blood supply in GC-induced ONFH remains unknown. In this study, we focused on the effect of CB2 in GC-induced ONFH and possible mechanisms in vitro and in vivo. By using GC-induced ONFH rat model, rat-bone mesenchymal stem cells (BMSCs) and human umbilical vein endothelial cells (HUVECs) to address the interaction of CB2 in vitro and in vivo, we evaluate the osteogenic and angiogenic effect variation and possible mechanisms. Micro-CT, histological staining, angiography, calcein labeling, Alizarin red staining (ARS), alkaline phosphatase (ALP), tartrate-resistant acid phosphatase (TRAP) staining, TUNEL staining, migration assay, scratch assay, and tube formation were applied in this study. Our results showed that selective activation of CB2 alleviates GC-induced ONFH. The activation of CB2 strengthened the osteogenic activity of BMSCs under the influence of GCs by promotion of GSK-3β/β-catenin signaling pathway. Furthermore, CB2 promoted HUVECs migration and tube-forming capacities. Our findings indicated that CB2 may serve as a rational new treatment strategy against GC-induced ONFH by osteogenesis activation and maintenance of blood supply. Subject terms: Prognostic markers, Calcium and phosphate metabolic disorders 相似文献
80.
Haoran Yang Qingmei Deng Tun Ni Yu liu Li Lu Haiming Dai Hongzhi Wang Wulin Yang 《International journal of biological sciences》2021,17(15):4207
Rationale: Nonalcoholic steatohepatitis (NASH), as one of the key stages in the development of nonalcoholic fatty liver disease (NAFLD), can directly progress to HCC, but the underlying mechanism is not fully understood.Methods: Differentially expressed genes (DEGs) in each stage of disease development were studied through a GEO dataset deriving from a Stelic Animal Model (STAM), which can simulate the evolution of NAFLD/NASH to HCC in humans. GSVA analysis was performed to analyze the differentially expressed oncogenic signatures in each stage. A human NAFLD-related dataset from GEO database was utilized for gene expression verification and further validated in the protein level in STAM mice. Small molecule inhibitors were applied to STAM mice for investigating whether inhibition of the LPL/FABP4/CPT1 axis could prevent the occurrence of NASH-related HCC in vivo. Microsphere formation and clonal formation assays in vitro were applied to study if inhibition of the LPL/FABP4/CPT1 axis can reduce the viability of liver cancer stem cells (LCSCs).Results: We found that upregulation of the LPL/FABP4/CPT1 molecular axis, as a fatty acid metabolic reprogramming process, occurred specifically during the NASH phase. GSVA analysis showed widespread activation of a large number of oncogenic signals, which may contribute to malignant transformation during NASH. Furthermore, inhibition of the LPL/FABP4/CPT1 axis could effectively delay the tumor growth in STAM mice. Cell assays revealed inhibitors targeting this axis can significantly reduce the sphere-forming, proliferation, and clonality of LCSCs.Conclusion: These results suggest that activation of the LPL/FABP4/CPT1 axis is essential for LCSCs maintenance, which acts synergistically with a variety of up-regulated oncogenic signals that drive the hepatocyte-LCSCs transdifferentiation during NASH to HCC progression. Thus, targeting the LPL/FABP4/CPT1 axis may provide a potential direction for NASH-related HCC prevention. 相似文献